FDA recall Z-0201-2022

Medtronic Neuromodulation · Class II · device

Product

Clinician Programmer Application (CPA) model A610 Clinician Software Application

Reason for recall

A software anomaly may occur with the clinician programmer application.

Distribution

Worldwide distribution - US Nationwide distribution and the countries of Australia, New Zealand, Canada, Europe, India, Japan, Korea, Middle East, Latin America, Africa, SE Asia and China.

Key facts

Status
Ongoing
Initiation date
2021-09-23
Report date
2021-11-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Minneapolis, MN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0201-2022